DAMANTE, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 26.255
AS - Asia 9.420
EU - Europa 6.526
SA - Sud America 1.574
Continente sconosciuto - Info sul continente non disponibili 635
AF - Africa 247
OC - Oceania 8
Totale 44.665
Nazione #
US - Stati Uniti d'America 25.883
SG - Singapore 4.353
CN - Cina 1.876
UA - Ucraina 1.475
BR - Brasile 1.225
IT - Italia 1.069
DE - Germania 1.021
HK - Hong Kong 884
VN - Vietnam 782
FI - Finlandia 607
RU - Federazione Russa 597
FR - Francia 403
SE - Svezia 329
IN - India 315
IE - Irlanda 298
GB - Regno Unito 267
TR - Turchia 255
CA - Canada 208
BD - Bangladesh 207
AR - Argentina 136
KR - Corea 104
IR - Iran 83
IQ - Iraq 81
JP - Giappone 81
ZA - Sudafrica 77
MX - Messico 75
BE - Belgio 71
PK - Pakistan 67
PL - Polonia 66
NL - Olanda 61
EC - Ecuador 59
AT - Austria 48
ES - Italia 47
SA - Arabia Saudita 45
ID - Indonesia 43
CO - Colombia 38
CZ - Repubblica Ceca 30
UZ - Uzbekistan 30
EG - Egitto 29
PH - Filippine 29
VE - Venezuela 29
MA - Marocco 28
PY - Paraguay 28
CL - Cile 26
RO - Romania 25
AE - Emirati Arabi Uniti 24
KE - Kenya 23
TG - Togo 22
EU - Europa 19
JM - Giamaica 17
IL - Israele 16
JO - Giordania 16
RS - Serbia 16
TN - Tunisia 16
UY - Uruguay 16
AZ - Azerbaigian 14
LT - Lituania 14
MY - Malesia 14
NP - Nepal 13
BH - Bahrain 12
DZ - Algeria 12
LB - Libano 12
DO - Repubblica Dominicana 11
KZ - Kazakistan 10
PA - Panama 10
PS - Palestinian Territory 10
XK - ???statistics.table.value.countryCode.XK??? 10
BG - Bulgaria 9
ET - Etiopia 9
TH - Thailandia 9
AU - Australia 8
CR - Costa Rica 8
HR - Croazia 8
HU - Ungheria 8
PE - Perù 8
AL - Albania 7
CH - Svizzera 7
TT - Trinidad e Tobago 7
GR - Grecia 6
GT - Guatemala 6
LV - Lettonia 6
PT - Portogallo 6
SN - Senegal 6
TW - Taiwan 6
BO - Bolivia 5
DK - Danimarca 5
HN - Honduras 5
OM - Oman 5
PR - Porto Rico 5
GA - Gabon 4
KG - Kirghizistan 4
LK - Sri Lanka 4
MU - Mauritius 4
BZ - Belize 3
LI - Liechtenstein 3
LU - Lussemburgo 3
NI - Nicaragua 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TJ - Tagikistan 3
Totale 44.003
Città #
Fairfield 2.753
Ashburn 2.309
Woodbridge 2.055
Singapore 1.943
Chandler 1.411
Houston 1.408
Seattle 1.182
Ann Arbor 1.107
Wilmington 1.037
Jacksonville 970
Cambridge 956
San Jose 914
Beijing 880
Hong Kong 876
Council Bluffs 699
Dearborn 626
Los Angeles 477
Chicago 448
Boardman 413
Udine 317
Lauterbourg 307
Dublin 294
New York 289
Princeton 278
Ho Chi Minh City 258
Munich 200
Salt Lake City 192
Izmir 187
Buffalo 184
Dallas 157
The Dalles 155
Hanoi 140
Hefei 133
San Diego 133
Santa Clara 132
Helsinki 110
São Paulo 109
Seoul 95
Ogden 94
Tampa 91
Redmond 88
Redondo Beach 88
Des Moines 85
Elk Grove Village 83
Frankfurt am Main 83
Milan 78
Phoenix 78
Dong Ket 73
Turku 73
Norwalk 70
Tokyo 69
Brussels 66
Montreal 61
Sterling 59
Mumbai 57
Orem 57
Columbus 56
Warsaw 56
Trieste 53
Atlanta 48
Rio de Janeiro 47
San Mateo 47
Brooklyn 46
Ottawa 46
Augusta 45
Chennai 45
Pittsburgh 45
Johannesburg 44
Kunming 44
Lancaster 43
London 40
Leawood 39
Toronto 39
Baghdad 38
Denver 38
Düsseldorf 36
Stockholm 36
Belo Horizonte 35
Miami 35
Nanjing 35
Poplar 35
Washington 35
Rome 34
Falls Church 33
Grafing 33
Nuremberg 33
Ardabil 31
Da Nang 31
Amsterdam 30
Guangzhou 30
Mexico City 28
Vienna 28
Tashkent 27
Ankara 26
Boston 25
Brasília 25
Kansas City 25
San Francisco 25
Detroit 23
Dulles 23
Totale 29.103
Nome #
Critical involvement of calcium-dependent cytosolic phospholipase A2α in aortic valve interstitial cell calcification 1.102
Effects of dihydrotanshinone I on proliferation and invasiveness of paclitaxel-resistant anaplastic thyroid cancer cells 492
Fetal growth at term and placental oxidative stress in a tissue micro-array model: a histological and immunohistochemistry study 346
Functional analysis of a novel RUNX2 missense mutation found in a family with cleidocranial dysplasia 276
A 16q deletion involving FOXF1 enhancer is associated to pulmonary capillary hemangiomatosis 233
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 227
Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells 225
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology 224
Comparative stability analysis of the thyroid transcription factor 1 and Antennapedia homeodomains: evidence for residue 54 in controlling the structural stability of the recognition helix 223
Evaluating the SERCA2 and VEGF mRNAs as Potential Molecular Biomarkers of the Onset and Progression in Huntington's Disease 222
APE1/Ref-1 regulates PTEN expression mediated by EGR-1 212
Enantioselective Cytotoxicity of Chiral Diphosphine Ruthenium(II) Complexes Against Cancer Cells 210
Expression of periostin in human breast cancer 208
BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells 208
Down-regulation of SM22/transgelin gene expression during H9c2 cells differentiation 206
Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: a novel tumorigenic pathway 205
Genomic Deletion Involving the IMMP2L Gene in Two Cases of Autism Spectrum Disorder 203
Expression of differentiation markers in cultured cells from various thyroid diseases 201
High periostin expression correlates with aggressiveness in papillary thyroid carcinomas 201
A Proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells 199
Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. 199
Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells 197
Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers 196
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation 195
THE ROLE OF CYP3A5 GENOTYPE AND TACROLIMUS MONITORING IN STABLE KIDNEY TRANSPLANTATIONS 194
Co-operation between the PAI and RED subdomains of Pax-8 in the interaction with the thyroglobulin promoter. 193
Somatic amplifications and deletions in genome of papillary thyroid carcinomas 193
Histone post-translational modifications induced by histone deacetylase inhibition in transcriptional control units of NIS gene 192
Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics. 192
Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells 192
Galectin-3 expression in non-small cell lung carcinoma 190
IGF-I increases c-fos expression in FRTL5 rat thyroid cells by activating the c-fos promoter 188
A suppressor of transcriptional activity is present upstream from the rat c-Ha-ras promoter 188
TSH stimulates the activity of the c-fos promoter in FRTL5 rat thyroid cells 188
Temperament and character inventory in bipolar disorder versus healthy controls and modulatory effects of 3 key functional gene variants 188
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer. 187
A molecular code dictates sequence-specific DNA recognition by homeodomains 187
Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP 186
In the TTF-1 homeodomain the contribution of several amino acids to DNA recognition depends on the bound sequence 185
Structural and functional properties of the N transcriptional activation domain of thyroid transcription factor-1: similarities with the acidic activation domains 185
BRCA2 GERMLINE MUTATIONS IN PRIMARY CANCER OF THE FALLOPIAN TUBE 185
Histone post-translational modifications associated to BAALC expression in leukemic cells. 183
Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells 183
Microduplication in the 2p16.1p15 chromosomal region linked to developmental delay and intellectual disability 182
FREQUENCY OF FACTOR V, PROTHROMBIN AND METHYLENETETRAHYDROFOLATE REDUCTASE GENE VARIANTS IN PREECLAMPSIA 180
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness 180
Definition of the DNA-binding specificity of TTF-1 homeodomain by chromatographic selection of binding sequences 179
Nanoparticles loaded with the BET inhibitor JQ1 block the growth of triple negative breast cancer cells in vitro and in vivo 179
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches 178
Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer 177
Analysis of the solution structure of the homeodomain of rat thyroid transcription factor 1 by 1H-NMR spectroscopy and restrained molecular mechanics 176
A differential proteomic approach to identify proteins associated with thyroid cell transformation 176
A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma 175
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization 175
Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver 175
A network of specific minor-groove contacts is a common characteristic of paired-domain-DNA interactions 174
Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia. 174
Studies on the promoter region of the c-Ha-ras gene in FRTL5 rat thyroid cells. 173
Nucleophosmin is overexpressed in thyroid tumors 173
CACNA1C haploinsufficiency accounts for the common features of interstitial 12p13.33 deletion carriers 172
PAX8 expression in human bladder cancer. 170
Homology model building of the thyroid transcription factor 1 homeodomain 169
Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN 169
Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. 168
Thyrotropin regulation of thyroid peroxidase messenger ribonucleic acid levels in cultured rat thyroid cells: evidence for the involvement of a nontranscriptional mechanism. 167
A CGH array procedure to detect PAX6 gene structural defects 166
Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. 165
Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer. 165
Differential proteomic analysis of nuclear extracts from thyroid cell lines 165
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma 163
Microdeletion 15q26.2qter and Microduplication 18q23 in a patient with prader-willi-like syndrome: Clinical findings 163
Blood-brain barrier dysfunction in disorders of the developing brain 163
Redox effector factor-1 regulates the activity of thyroid transcription factor 1 by controlling the redox state of the N transcriptional activation domain 162
Molecular events in the differentiation of the thyroid gland 162
Myelin protein zero Val102fs mutation manifesting with isolated spinal root hypertrophy. 162
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring 162
Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomics 161
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells 160
Desensitization of the thyroid cyclic AMP response to thyroid stimulating immunoglobulin: comparison with TSH 159
Erratum: Functional regulation of the Apurinic/apyrimidinic endonuclease APE1 by Nucleophosmin (NPM1): Impact on tumor biology 159
TSH controls ref-1 nuclear translocation in thyroid cells 159
Control of phosphatase and tensin homolog (PTEN) gene expression in normal and neoplastic thyroid cells 159
APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC 159
Thyroid-specific gene expression. 158
Mutations R67X and W303X of the protein Z-dependent protease inhibitor gene and venous thromboembolic disease: a case-control study in Italian subjects 158
The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines. 157
KRAS Codons 12 and 13 Mutation Analysis: A Comparative Study between Direct Sequencing and a New Sensitive Real-Time PCR Assay 157
Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma 156
Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma Cells 156
An 'environment to nucleus' signaling system operates in B lymphocytes: redox status 156
Insulin binding and biological activities in the FRTL-5 rat thyroid cell line. 155
Unexpected phenotype of a typical NPM1 mutant 154
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours. 154
Investigation of endothelin-1 type A receptor gene polymorphism (-231 G>A) in preeclampsia susceptibility 153
A unique combination of transcription factors controls differentiation of thyroid cells 151
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 151
Mitochondrial localization of APE/Ref-1 in thyroid cells 151
Cyclic AMP-response element modulator inhibits the promoter activity of the sodium iodide symporter gene in thyroid cancer cells. 151
Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy 151
A simple multiplex real-time PCR methodology for the SMN1 gene copy number quantification 151
Totale 19.364
Categoria #
all - tutte 160.320
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.320


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.510 0 222 80 125 102 121 171 132 40 410 744 363
2022/20232.951 322 291 49 412 281 758 6 247 389 34 98 64
2023/20241.177 149 73 42 25 182 234 16 65 141 70 43 137
2024/20255.990 115 361 255 321 284 263 445 344 692 450 937 1.523
2025/202613.762 1.362 2.339 996 1.272 1.789 925 1.493 338 907 1.027 768 546
2026/2027847 264 583 0 0 0 0 0 0 0 0 0 0
Totale 44.665